Saltar al contenido principal

A Tribute to Paul Greengard (1925-2019)

  • 1 Edición, Volumen 90 - 2 de marzo de 2021
  • Última edición
  • Editor: Stevin H. Zorn
  • Idioma: Inglés

A Tribute to Paul Greengard, Volume 90, the latest release in the Advances in Pharmacology series presents a variety of chapters from the best authors in the field, with this rel… Leer más

Descripción

A Tribute to Paul Greengard, Volume 90, the latest release in the Advances in Pharmacology series presents a variety of chapters from the best authors in the field, with this release presenting a tribute to Paul Greengard.

Puntos claves

  • Includes the authority and expertise of leading contributors in pharmacology
  • Presents the latest release in the Advances in Pharmacology series

De interès para

Investigators in neuroscience, pharmacology, neurology, psychiatry, medicine

Índice

1. Paul Greengard: A persistent desire to comprehend the brain, and also to fix it
Marc Flajolet, Thu Lan N-Guyen, Vijay Kumar Siripuram and Yashoda Krishna Sunkari

2. Giving names to the actors of synaptic transmission: The long journey from synaptic vesicles to neural plasticity
Fabio Benfenati, Martin Bähler and Flavia Valtorta

3. cAMP-regulated phosphoproteins DARPP-32, ARPP16/19, and RCS modulate striatal signal transduction through protein kinases and phosphatases
Kyle R. Christensen and Angus C. Nairn

4. DARPP-32 40 years later
Jean-Antoine Girault and Angus C. Nairn

5. Effects of nicotine on DARPP-32 and CaMKII signaling relevant to addiction
Angela M. Lee and Marina R. Picciotto

6. Modulation of dendritic spines by protein phosphatase-1
Jimcy Platholi and Hugh C. Hemmings Jr

7. Deciphering cell-type specific signal transduction in the brain: Challenges and promises
Jean-Pierre Roussarie and Patricia Rodriguez-Rodriguez

8. Drug-activated cells: From immediate early genes to neuronal ensembles in addiction
Marine Salery, Arthur Godino and Eric J. Nestler

9. NAPE-specific phospholipase D regulates LRRK2 association with neuronal membranes
Francesca Palese, Silvia Pontis, Natalia Realini and Daniele Piomelli

10. Amyloidogenic and anti-amyloidogenic properties of presenilin 1
Victor Bustos, Maria Pulina and Jose Ledo

11. A review of the pharmacology and clinical profile of lumateperone for the treatment of schizophrenia
Gretchen L Snyder, Kimberly E Vanover, Robert E Davis, Peng Li, Allen Fienberg and Sharon Mates

12. Uniting homeostatic plasticity and exosome biology: A revision of the conceptual framework for drug discovery in neurodegenerative diseases?
James K.T. Wang

Detalles del producto

  • Edición: 1
  • Última edición
  • Volumen: 90
  • Publicado: 2 de marzo de 2021
  • Idioma: Inglés

Sobre el editor

SZ

Stevin H. Zorn

Stevin Zorn is President and CEO at MindImmune Therapeutics, Inc., Kingston, RI, USA
Afiliaciones y experiencia
President and CEO, MindImmune Therapeutics, Inc., Kingston, RI, USA

Ver libro en ScienceDirect

Lee A Tribute to Paul Greengard (1925-2019) en ScienceDirect